Officers

Dr. John Keller (President)
Senior Executive Officer
Shionogi & Co., Ltd.

Ms. Brianne Weingarten (Vice President)
Vice President, Business Operations
Purdue Pharma L.P.

Mr. Mitsuo Kosaka (Secretary)
Vice President, U.S. Payer Markets & Corporate Strategy
Eisai Inc.

Members of
The Board of Directors

Dr. Rana Al-Hallaq
Principal
Pfizer Ventures

Dr. Alex Chang
Executive Director Business Development
Helsinn Therapeutics (U.S.) Inc.

Ms. Theresa Covert
VP, Business Development/Developed Markets,
Global Human Health
Merck & Co., Inc.

Mr. Tuyen Do
Sr. Director, New Product Planning and Business Development
Taiho Oncology, Inc.

Dr. Toby Freyman
Director, Business Development
Shire

Dr. Hiroshi Kawai
Vice President, Business Development
Mitsubishi Tanabe Pharma Holdings America, Inc.

Mr. Sang Le
Senior Director of Alliance Management
Otsuka America Pharmaceuticals

Mr. Kazumi Taguchi 
President
Kyorin USA Inc.

Dr. Jeffrey Warmke
Senior Vice President, External Scientific Affairs & Alliance Management, Global Business Development                                                       Daiichi Sankyo Inc.

Mr. Shoji Yasuda
President
Taisho Pharmaceutical R&D Inc.